Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30:13:913514.
doi: 10.3389/fendo.2022.913514. eCollection 2022.

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants

Lisa Middendorf  1 , Alexandra Gellhaus  2 , Antonella Iannaccone  2 , Angela Köninger  2   3 , Anne-Kathrin Dathe  1   4   5 , Ivo Bendix  4   6 , Beatrix Reisch  2 , Ursula Felderhoff-Mueser  1   4 , Britta Huening  1   4
Affiliations

The Impact of Increased Maternal sFlt-1/PlGF Ratio on Motor Outcome of Preterm Infants

Lisa Middendorf et al. Front Endocrinol (Lausanne). .

Abstract

Background: The sFlt-1 (soluble fms-like tyrosine kinase-1)/PlGF (placental growth factor) ratio serves as a clinical biomarker to predict the hypertensive, placenta-derived pregnancy disorder pre-eclampsia which is often associated with placental dysfunction and fetal growth restriction. Additionally elevated levels also indicate an increased risk for prematurity. However, its predictive value for subsequent neonatal neurological outcome has not been studied.

Objective: This study aimed to evaluate the correlation of maternal sFlt-1/PlGF ratio with early motor outcome of preterm infants. Design/Methods: 88 preterm infants (gestational age ≤ 34 + 0) born between February 2017 and August 2020 at the Department of Obstetrics and Gynecology, University Hospital Essen in Germany, were included, when the following variables were available: maternal sFlt-1/PlGF levels at parturition and general movement assessment of the infant at the corrected age of 3 to 5 months. The infants were stratified into high and low ratio groups according to maternal sFlt-1/PlGF cut-off values of 85. To investigate the early motor repertoire and quality of spontaneous movements of the infant, the Motor Optimality Score (MOS-R) based on antigravity movements and posture patterns, was applied. In the given age, special attention was paid to the presence of fidgety movements. Linear regressions were run to test differences in infants motor repertoire according to the maternal sFlt-1/PIGF ratio.

Results: Linear regression analysis showed that the sFlt-1/PlGF ratio does not predict the MOS-R score (β=≤0.001; p=0.282). However, children with birth weight below the 10th percentile scored significantly lower (mean 20.7 vs 22.7; p=0.035). These children were 91% in the group with an increased ratio, which in turn is a known predictor of low birth weight (β= -0.315; p <0.001). In the group with a high sFlt-1/PLGF ratio above 85 the mothers of female infants had a lower average sFlt-1/PlGF ratio compared to a male infant (median: 438 in female vs. 603 in male infant, p=0.145).

Conclusions: In our cohort, especially low birth weight, which correlated with an elevated sFlt-1/PlGF ratio, had a negative effect on the outcome in the MOS-R. A direct correlation between an increased ratio and a worse motor outcome was not demonstrated.

Keywords: MOS-R; PIGF; infant; motor outcome; prematurity; sFlt-1.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Recruitment strategy and exclusion criteria. Notes. IVH= intraventricular hemorrhage, PVL= periventricular leukomalacia, a participants can fulfill multiple exclusion criteria.
Figure 2
Figure 2
Results of MOS-R as a function of sFlt-1/PlGF ratio. Notes. The ratio has been logarithmized for better presentation.
Figure 3
Figure 3
Correlation of birth weight percentile with sFlt-1/PlGF ratio. Notes. The ratio has been logarithmized for better presentation.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel J, et al. Pre-Eclampsia, Eclampsia and Adverse Maternal and Perinatal Outcomes: A Secondary Analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG: Int J Ob Gynaecol (2014) 121:14–24. doi: 10.1111/1471-0528.12629 - DOI - PubMed
    1. Schneider H, Baumann M. Präeklampsie, Pathogenese Und Vorhersage. Der Gynäkologe (2013) 46(3):193–8. doi: 10.1007/s00129-013-3140-z - DOI
    1. Roberts J. Endothelial Dysfunction in Preeclampsia. Semin Reprod Med (1998) 16(01):5–15. doi: 10.1055/s-2007-1016248 - DOI - PubMed
    1. Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, et al. Circulating Angiogenic Factors and the Risk of Preeclampsia. New Engl J Med (2004) 350(7):672–83. doi: 10.1056/nejmoa031884 - DOI - PubMed
    1. Vogtmann R, Heupel J, Herse F, Matin M, Hagmann H, Bendix I, et al. Circulating Maternal Sflt1 (Soluble Fms-Like Tyrosine Kinase-1) Is Sufficient to Impair Spiral Arterial Remodeling in a Preeclampsia Mouse Model. Hypertension (2021) 78(4):1067–79. doi: 10.1161/hypertensionaha.121.17567 - DOI - PMC - PubMed

Publication types

Substances